Prof. Zeng Qingjun | Gastrointestinal Tumors | Best Researcher Award

Posted on 26/11/202426/11/2024 by Pencis

Prof. Zeng Qingjun | Gastrointestinal Tumors | Best Researcher Award

Yueyang Central Hospital | China

AUTHOR PROFILE

📚EARLY ACADEMIC PURSUITS

ZENG QINGJUN completed his Master’s degree at Xiangya Medical College, Central South University, in 2010. This prestigious institution provided a strong foundation in medical education, equipping him with the skills and knowledge necessary for his future in the field of gastrointestinal surgery. His academic training allowed him to develop expertise in complex surgical techniques, laying the groundwork for his career as a clinical specialist in surgery.

⚕️PROFESSIONAL ENDEAVORS

Since July 2010, ZENG QINGJUN has been working in the field of gastrointestinal surgery, focusing on laparoscopic techniques for treating gastric and colorectal cancers. As a chief physician, he plays a pivotal role in leading surgical teams, performing high-risk surgeries, and making critical decisions for patient care. His clinical expertise and skillful handling of over 200 laparoscopic gastric cancer surgeries and 400 laparoscopic colorectal cancer surgeries are testaments to his proficiency in minimally invasive surgical methods. His surgical outcomes have contributed significantly to improving the quality of life for cancer patients and are recognized within the medical community.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON GASTROINTESTINAL TUMORS

Dr. ZENG has dedicated much of his professional life to the development and refinement of laparoscopic surgical techniques in the treatment of gastrointestinal cancers. His research is heavily focused on advancing minimally invasive surgery, particularly in the areas of gastric cancer and colorectal cancer. Through clinical trials and innovative methodologies, he has been involved in optimizing surgical procedures to ensure better postoperative recovery, reduced complications, and more efficient treatment pathways for cancer patients.

🌍IMPACT AND INFLUENCE

Dr. ZENG QINGJUN has made an immense impact on the practice of gastrointestinal surgery in China, particularly in the realm of laparoscopic surgery. His innovative approaches and commitment to cutting-edge techniques have influenced both local and national surgical practices. His contribution to gastric and colorectal cancer surgery has improved patient outcomes and has set new standards in the field. As a chief physician, he mentors younger surgeons and shares his expertise, ensuring the continued progress of surgical techniques.

📑ACADEMIC CITATIONS

While detailed citation metrics are not provided, Dr. ZENG’s extensive clinical experience and research endeavors have led to his recognition in academic circles. His focus on laparoscopic techniques and cancer surgery continues to influence current and future generations of surgeons and researchers in the field. His work, particularly in gastric and colorectal cancer, has made notable contributions to medical literature and has been referenced in various academic and clinical studies.

🌱LEGACY AND FUTURE CONTRIBUTIONS

Dr. ZENG QINGJUN’s career reflects a legacy of excellence in surgical practice and medical innovation. His pioneering work in laparoscopic surgery and cancer treatment has already set the stage for future breakthroughs in the field of gastrointestinal oncology. Looking forward, he is likely to contribute even more significantly to surgical research, possibly expanding his focus to robot-assisted surgeries, postoperative care advancements, and the integration of AI in surgical planning. His mentorship, both locally and nationally, will shape the future of surgical education and the next generation of gastrointestinal surgeons.

💼LEADERSHIP IN SURGICAL PRACTICE

Dr. ZENG continues to hold a significant leadership role in the surgical department at his medical institution. His capacity as chief physician enables him to make high-level decisions in clinical practice, direct surgical teams, and implement best practice guidelines. His strategic leadership in gastrointestinal surgery helps to establish protocols for laparoscopic surgeries, improving surgical outcomes, and pushing the boundaries of traditional approaches.

🔗 CONCLUSION

Dr. Zeng Qingjun is a distinguished gastrointestinal surgeon whose work has significantly advanced the field of laparoscopic surgery for gastric and colorectal cancers. With over a decade of experience and hundreds of successful surgeries, his contributions have set new standards in minimally invasive surgical techniques, improving patient outcomes and recovery times. Through his leadership as chief physician, he has not only influenced clinical practices but has also become a mentor to aspiring surgeons, ensuring the continuity of high-quality surgical education.

📊🔬NOTABLE PUBLICATION:

1. Title: Knockdown of BUB1B Inhibits the Proliferation, Migration, and Invasion of Colorectal Cancer by Regulating the JNK/c-Jun Signaling Pathway
Authors: Qingjun Zeng, Sanjun Zhang, Linfang He, Qingyan Fu, Li Liao, Linjie Chen, Xiang Ding
Journal: Cancer Biotherapy and Radiopharmaceuticals
Year: 2023

2. Title: Targeting of MAD2L1 by miR‐515‐5p involves the regulation of cell cycle arrest and apoptosis of colorectal cancer cells
Authors: Xiang Ding, Qingyan Fu, Weixing Chen, Linjie Chen, Qingjun Zeng, Sanjun Zhang, Linfang He
Journal: Cell Biology International
Year: 2022

Prof. Qingyong Chen | Head Tumors | Best Researcher Award

Posted on 12/10/202412/10/2024 by Pencis

Prof. Qingyong Chen | Head Tumors | Best Researcher Award

Binzhou Medical University | China

AUTHOR PROFILE

Scopus

🎓EARLY ACADEMIC PURSUITS

Chen Qingyong, M.S., began his academic journey with a strong foundation in clinical medicine, receiving his education from The Second School of Clinical Medicine at Binzhou Medical University. His early academic focus was centered around basic medical sciences, laying the groundwork for his expertise in bioinformatics, statistical methods, and biomedical research. His passion for learning and dedication to mastering complex subjects drove him to excel in the medical field, and he quickly became proficient in handling both theoretical and practical aspects of medical research.

👨‍⚕️PROFESSIONAL ENDEAVORS

As a Resident Physician at Binzhou Medical University, Chen Qingyong is immersed in both clinical practice and research. His responsibilities extend beyond patient care to encompass cutting-edge scientific investigations. He demonstrates an impressive ability to combine clinical knowledge with advanced computational tools, excelling in areas such as imaging genomics, machine learning, and deep learning for predictive modeling. Chen’s dual focus on clinical practice and medical research makes him a well-rounded medical professional with a unique skill set in modern healthcare technologies.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON HEAD TUMORS

Over the past year, Chen Qingyong has published 12 first-author papers, showcasing his proficiency in various advanced research methods, including Mendelian Randomization, Meta-Analysis, and basic experimental techniques. His research is particularly focused on leveraging bioinformatics to analyze complex medical data, contributing to the fields of imaging genomics and machine learning-based predictive models. Chen’s ability to utilize tools like R and Python has enabled him to derive meaningful insights from large datasets, advancing the understanding of disease mechanisms and aiding in the development of predictive diagnostics.

📊IMPACT AND INFLUENCE

Chen’s research is gaining recognition for its contributions to the intersection of clinical medicine and computational sciences. His work on deep learning algorithms and bioinformatics for predictive diagnostics is helping to shape the future of personalized medicine. His studies offer new avenues for improving patient outcomes through the integration of machine learning into clinical decision-making processes. Moreover, his proficiency in Meta-analysis and Mendelian randomization has added depth to the interpretation of epidemiological data, offering more robust conclusions on disease causality.

📚ACADEMIC CITATIONS AND RECOGNITION

Chen Qingyong’s research has been cited in several high-impact journals, reflecting the significance of his contributions to medical science. His ability to publish consistently and effectively within a short period demonstrates not only his dedication but also the growing interest and reliance on his work by the academic community. These citations solidify his position as an emerging researcher whose work holds importance for both current medical challenges and future innovations in healthcare.

🌟LEGACY AND FUTURE CONTRIBUTIONS

Chen Qingyong’s future appears promising as he continues to bridge the gap between medicine and technology. His focus on integrating deep learning and imaging genomics with clinical applications suggests that he will remain at the forefront of medical research innovations. His contributions are expected to have a lasting impact, particularly in the areas of personalized medicine, predictive diagnostics, and epidemiological research. As a young researcher with significant accomplishments already under his belt, Chen is poised to leave a profound legacy in both clinical practice and biomedical research.

✨CONCLUSION

Chen Qingyong is a rising star in the medical field, known for his extensive research in bioinformatics, machine learning, and genomics. His early accomplishments suggest a future of impactful discoveries and innovations that will shape the direction of modern healthcare. By merging clinical expertise with cutting-edge computational methods, Chen is paving the way for advancements in predictive medicine, ultimately improving patient care and outcomes.

📊🔬NOTABLE PUBLICATION:

- Predicting Biomarkers in Laryngeal Squamous Cell Carcinoma Based on the Cytokine-Cytokine Receptor Interaction Pathway
  
  Authors: Chen, Q., Wang, D., Chen, Z., Li, P., Lv, H.
  
  Journal: Heliyon
  
  Year: 2024
- Application of Retroauricular Sulcus Incision in the Operation of Benign Tumors in the Deep Lobe of Parotid Gland
  
  Authors: Chen, Q., Sun, D., Wang, D., Yang, Y., Lyu, H.
  
  Journal: Chinese Journal of Otorhinolaryngology Head and Neck Surgery
  
  Year: 2023

Dr. Pengchong Wang | Cancer Therapy | Best Researcher Award

Posted on 27/09/202427/09/2024 by Pencis

Dr. Pengchong Wang | Cancer Therapy | Best Researcher Award

Shaanxi Provincial People’s Hospital | China

AUTHOR PROFILE

Scopus

💊 WANG PENGCHONG: ACADEMIC PROFILE AND ACHIEVEMENTS 🎓

🎓EARLY ACADEMIC PURSUITS 📚

Wang Pengchong, the Chief Pharmacist at Shaanxi Provincial People’s Hospital, earned his PhD in Pharmacy from Xi’an Jiaotong University. His academic journey was shaped by a focus on tumor pharmacy and targeted drug delivery systems. His early years were spent delving into the intricacies of pharmaceutical care, particularly in the context of oncology, laying the foundation for his future breakthroughs.

💼 PROFESSIONAL ENDEAVORS 🏥

Wang is a dedicated member of the Pharmaceutical Care Committee of the Shaanxi Pharmacological Society. His professional work has revolved around tumor pharmacology, pioneering approaches to targeted cancer treatments. He has played an instrumental role in several major projects, including three general projects funded by the National Natural Science Foundation of China and two key R&D projects in Shaanxi Province. His leadership in high-profile initiatives highlights his influence on pharmaceutical advancements.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS 🎯

Wang Pengchong’s research is centered on targeted drug delivery systems and tumor pharmacy research. His contributions are geared toward improving cancer therapies by focusing on precision medicine, which minimizes side effects and enhances the effectiveness of treatment. His work extends into innovative methods, such as nanotechnology in drug targeting. Wang has led multiple significant projects, including the Shaanxi Province Science and Technology Plan Project, the Xi’an City Science and Technology Plan Project, and the Yaodong Shenzhou Pharmaceutical Research Capacity Building Project.

✨ IMPACT AND INFLUENCE 🌐

Wang’s research has had a profound impact on cancer treatment strategies and pharmaceutical care. His efforts have advanced both the scientific understanding and practical application of cancer drugs, particularly in how they can be precisely targeted to tumor cells while sparing healthy tissues. Through his leadership in government-backed research initiatives, Wang has become a driving force in the field, influencing not just Shaanxi Province but the broader pharmaceutical landscape.

📊 ACADEMIC CITES 📄

In the past five years, Wang Pengchong has published more than ten SCI-indexed papers in international journals. His work is widely cited, particularly in oncology and pharmaceutical sciences. His research topics span from cutting-edge drug delivery systems to therapeutic advancements, solidifying his reputation in the global scientific community.

🌍 LEGACY AND FUTURE CONTRIBUTIONS 🏆

Wang Pengchong’s legacy will continue to grow as he contributes to targeted cancer therapies and pharmaceutical innovations. His role in advancing precision medicine ensures that his work will influence the next generation of cancer treatments. By leading critical projects and setting new benchmarks in oncology pharmacy, Wang is shaping the future of drug delivery systems and cancer care. His ongoing commitment to pharmaceutical research guarantees that his contributions will leave a lasting impact on the field.

📈 CONCLUSION 🌟

Wang Pengchong’s distinguished career as a Chief Pharmacist and researcher has made significant strides in the fields of targeted drug delivery systems and tumor pharmacy. His academic foundation, coupled with leadership in high-impact research projects, has not only advanced cancer treatment but also positioned him as a key contributor to pharmaceutical sciences. With over a decade of impactful publications and successful project leadership, Wang’s research continues to shape the future of oncology treatments, fostering innovations that will benefit patients worldwide. His work embodies a lasting legacy of precision medicine and cutting-edge cancer therapies, ensuring he remains a pivotal figure in pharmaceutical research and development. 🌍🔬

📊🔬NOTABLE PUBLICATION:

- Mucoadhesive nanoparticles-based oral drug delivery systems enhance ameliorative effects of low molecular weight heparin on experimental colitis
  
  Authors: Yan, Y., Sun, Y., Wang, P., Xing, J., Dong, Y.
  
  Journal: Carbohydrate Polymers
  
  Year: 2020
- An improved synthesis of water-soluble dual fluorescence emission carbon dots from holly leaves for accurate detection of mercury ions in living cells
  
  Authors: Wang, P., Yan, Y., Zhang, Y., Xing, J., Dong, Y.
  
  Journal: International Journal of Nanomedicine
  
  Year: 2021
- One-pot synthesis of nuclear targeting carbon dots with high photoluminescence
  
  Authors: Wang, P., Ji, H., Guo, S., Xing, J., Dong, Y.
  
  Journal: Chinese Chemical Letters
  
  Year: 2021
- Hyaluronic acid-based M1 macrophage targeting and environmental responsive drug releasing nanoparticle for enhanced treatment of rheumatoid arthritis
  
  Authors: Wang, P., Zhang, Y., Lei, H., Xing, J., Dong, Y.
  
  Journal: Carbohydrate Polymers
  
  Year: 2023
- Multifunctional nanosystems sequentially regulating intratumor Fenton chemistry by remodeling the tumor microenvironment to reinforce chemodynamic therapy
  
  Authors: Dong, K., Chen, W., Zhao, Z., Lu, T., Dong, Y.
  
  Journal: Biomaterials Advances
  
  Year: 2022

Dr Jianjun Xu | Hepatobiliary Oncology and Cancer | Best Researcher Award

Posted on 08/06/202413/09/2024 by Pencis

Dr Jianjun Xu | Hepatobiliary Oncology and Cancer | Best Researcher Award

Union Hospital, Tongii Medical | China

Author Profile

Scopus

Orcid id

🏥 Dr. Jianjun Xu: Pioneering Hepatobiliary Oncology Specialist

👨‍⚕️ Full Name: Jianjun Xu

🏅 Designation: Attending Doctor

🏨 Department:

Department of Hepatobiliary Surgery
Center for Liver Transplantation

🎓 Qualification: Doctor

🔬 Area of Specialization: Hepatobiliary Oncology and Cancer

💡 Sub Division: Oncology Therapeutics and Novel Approaches

🕒 Total Experience:

Work for 2 years
Doctor for 3 years
Master for 3 years
Bachelor for 5 years

🎓 Education

📚 2011-2016: Bachelor of Clinical Medicine, School of Medicine, Nanchang University.

🎓 2016-2019: Master of Surgery, Tongji Medical College, Huazhong University of Science and Technology.

🏫 2019-2022: Doctor of Surgery, Tongji Medical College, Huazhong University of Science and Technology.

🏥 Experience

🩺 July 2022 to Present: Attending Doctor at Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Wuhan 430022, China.

🔬 Contributions to Research, Innovations, and Extension Activities On Hepatobiliary Oncology and Cancer

Throughout his tenure, Dr. Jianjun Xu has made significant contributions to Tumor Research & Development, Innovations, and Extension Activities. Actively participating in research projects, he has advanced the understanding of tumor biology, therapeutic interventions, and patient care outcomes. Leveraging his expertise in hepatobiliary malignancies, Dr. Xu collaborates with interdisciplinary teams to identify novel biomarkers, therapeutic targets, and treatment modalities, aiming to improve patient outcomes and quality of life.

Dr. Xu has also been involved in innovative initiatives to translate research findings into clinical practice. By fostering partnerships with industry stakeholders, academic institutions, and healthcare providers, he has facilitated the development and implementation of cutting-edge technologies and treatment approaches in oncology.

In addition to his research endeavors, Dr. Xu actively engages in extension activities to disseminate knowledge and promote awareness of cancer prevention, early detection, and treatment options within the community. Through educational workshops, public seminars, and outreach programs, he empowers patients, caregivers, and healthcare professionals with the necessary information and resources to combat cancer effectively. His dedication to advancing cancer research, innovation, and community outreach underscores his commitment to making a meaningful impact in the fight against cancer.

NOTABLE PUBLICATION:

Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma

Citation: 52 Year: 2021

High PPT1 expression predicts poor clinical outcome and PPT1 inhibitor DC661 enhances sorafenib sensitivity in hepatocellular carcinoma

Citation: 18 Year: 2022

Systemic immune-inflammation index predicts postoperative acute kidney injury in hepatocellular carcinoma patients after hepatectomy

Citation: 09 Year: 2021

Laparoscopic resection of hepatic epithelioid hemangioendothelioma: report of eleven rare cases and literature review

Citation: 05 Year: 2020

Light-triggered polymeric prodrug and nano-assembly for chemo-photodynamic therapy and potentiate immune checkpoint blockade immunotherapy for hepatocellular carcinoma

Citation: 02 Year: 2023

Cancer Treatment, Therapies and Nursing

Posted on 07/10/202313/10/2023 by Pencis

Cancer Treatment, Therapies and Nursing

Introduction: Cancer Treatment, Therapies, and Nursing represent the multifaceted approach to addressing cancer, combining cutting-edge medical interventions, supportive care, and compassionate nursing to improve patient outcomes and enhance their quality of life. These components are integral in the comprehensive battle against cancer.

Subtopics in Cancer Treatment, Therapies, and Nursing:

Oncology Nursing and Patient Care: Explore the pivotal role of oncology nurses in providing personalized care, managing symptoms, and offering emotional support to cancer patients throughout their treatment journey.

Surgery in Cancer Treatment: Delve into the various surgical procedures used to remove tumors, biopsy tissues, and reconstruct affected areas, and their significance in the overall cancer treatment plan.

Radiation Therapy: Understand the principles and advancements in radiation therapy, including techniques like IMRT and proton therapy, and how they target cancer cells while minimizing damage to healthy tissue.

Chemotherapy and Targeted Therapies: Examine the different types of chemotherapy and targeted therapies, their mechanisms of action, and the evolving landscape of drug development in cancer treatment.

Palliative and Supportive Care: Explore the importance of palliative care in managing cancer-related symptoms, improving the patient’s quality of life, and addressing end-of-life considerations, alongside the crucial role of supportive care services.

Integrative and Complementary Therapies: Investigate complementary approaches such as acupuncture, yoga, and mindfulness, which can complement traditional cancer treatments and aid in symptom management and emotional well-being.

Precision Medicine in Oncology: Understand how precision medicine tailors cancer treatment to an individual’s genetic and molecular profile, optimizing therapy selection and minimizing side effects.

Survivorship Programs: Learn about survivorship programs that focus on the long-term health and well-being of cancer survivors, addressing physical, psychological, and social aspects of post-treatment life.

Emerging Therapies and Clinical Trials: Explore promising experimental therapies and the importance of clinical trials in advancing cancer treatment options, as well as the roles

Medical Oncology

Posted on 07/10/202313/10/2023 by Pencis

Medical Oncology

Introduction to Medical Oncology: Medical Oncology is a specialized branch of medicine dedicated to the diagnosis, treatment, and management of cancer. This field plays a pivotal role in improving the lives of cancer patients through various treatment modalities and cutting-edge research. Within the realm of Medical Oncology, several key subtopics are essential for understanding and addressing the complexities of cancer care:

Chemotherapy and Targeted Therapies: Chemotherapy involves the use of drugs to kill or slow the growth of cancer cells, while targeted therapies focus on specific molecular abnormalities within cancer cells. Understanding these treatment options is crucial for medical oncologists to tailor therapies for individual patients.

Immunotherapy: Immunotherapy harnesses the body’s immune system to combat cancer. This groundbreaking approach has revolutionized cancer treatment by enhancing the body’s natural defenses against cancer cells.

Precision Medicine: Precision medicine in oncology involves customizing treatment plans based on a patient’s unique genetic and molecular profile. It allows for more personalized and effective cancer treatments, minimizing side effects.

Palliative Care: Palliative care in Medical Oncology is vital for improving the quality of life for cancer patients. It focuses on symptom management, pain relief, and emotional support to enhance patients’ overall well-being.

Clinical Trials and Research: Ongoing research and clinical trials are at the forefront of Medical Oncology. Investigating new treatments, therapies, and breakthroughs in cancer care is essential for improving patient outcomes and advancing the field.

These subtopics illustrate the multidimensional nature of Medical Oncology, where a comprehensive approach is taken to address the complexities of cancer treatment and patient care.